(MedPage Today) -- Defense Secretary Pete Hegseth announced Wednesday that he is rolling out a new screening program for "testosterone deficiency" among troops, calling it necessary to allow them to operate at their "absolute best." The new screenings...
(MedPage Today) -- At the International Symposium on Pediatric Neuro-Oncology (ISPNO), investigators reported prospective evidence supporting retreatment with the MEK inhibitor selumetinib (Koselugo) in children with recurrent low-grade glioma...
(MedPage Today) -- HHS Secretary Robert F. Kennedy Jr. wanted to push even harder against vaccines than what he ultimately put forward as policy. He wanted to spend $5 billion to study the link between vaccines and autism, and completely do away...
(MedPage Today) -- Two active ingredients found in marijuana -- tetrahydrocannabinol (THC) and cannabidiol (CBD) -- led to significantly less agitation in hospice-eligible patients with Alzheimer's disease and other dementias, the phase II...
(MedPage Today) -- Heavy smoke from several large wildfires blazing in Canada and Minnesota is expected to engulf large swaths of the Midwest and Northeast U.S. this week, exposing millions of people to dangerous air pollution. Minnesota officials...
(MedPage Today) -- Note that some links may require registration or subscription. A preprint study flagged signals of frailty in seniors taking the GLP-1 drug tirzepatide (Zepbound) for weight loss. (Reuters via Yahoo!) The House passed a bill...
A federal judge dismissed another lawsuit brought by an Elevance health plan alleging the billings intermediary was gaming the arbitration process set up by the No Surprises Act.
Physician groups said the sweeping rule is a double-edged sword, given it includes an unwelcome fee cut but positive changes to Medicare’s value-based and quality payment programs.
Elevance will leave D.C. this summer and is considering other markets to depart, executives said. The company outperformed Wall Street expectations in the second quarter — but not by much, and its stock fell accordingly.
Amanda Chawla comes to the Washington-based nonprofit giant from Stanford Medicine. Providence is hoping her appointment will bolster its supply chain capabilities during a time of elevated spend.